Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

T2 mapping of molecular subtypes of WHO grade II/III gliomas.

BMC neurology - 8 Jan 2020

Kern Maike, Auer Timo Alexander, Picht Thomas, Misch Martin, Wiener Edzard

Abstract excerpt

BACKGROUND: According to the new WHO classification from 2016, molecular profiles have shown to provide reliable information about prognosis and treatment response. The purpose of our study is to evaluate the diagnostic potential of non-invasive quantitative T2 mapping in the detection of IDH1/2 mutation status in grade II-III gliomas. METHODS: Retrospective evaluation of MR examinations in 30 patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Glioma
Share to Image Interpretation, Computer-Assisted

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Magnetic Resonance Imaging

Share to Neuroimaging

Share to Prognosis

Share to World Health Organization

Source

Open in PubMed Open full text

Identifiers

PMID: 31914945
DOI: 10.1186/s12883-019-1590-1
PMCID: PMC6947951

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

T2 mapping of molecular subtypes of WHO grade II/III gliomas.PMID 31914945Read ↗

Multivariable non-invasive association of isocitrate dehydrogenase mutational status in World Health Organization grade II and III gliomas with advanced magnetic resonance imaging T2 mapping techniques.Semantic proximity Read ↗

Feasibility of Evaluating the Histologic and Genetic Subtypes of WHO Grade II-IV Gliomas by Diffusion-Weighted ImagingSemantic proximity Read ↗

T2 mapping of the peritumoral infiltration zone of glioblastoma and anaplastic astrocytoma.Semantic proximity Read ↗

Time-dependent diffusion MRI-based microstructural mapping for predicting IDH mutation status in glioma: A multicenter study.Semantic proximity Read ↗

WHO CNS5 2021 includes specific mutations in gliomas that can be identified with MRI quantitative biomarkers.Semantic proximity Read ↗

Identification of T2W hypointense ring as a novel noninvasive indicator for glioma grade and IDH genotype.Semantic proximity Read ↗

Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.Semantic proximity Read ↗

Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.Semantic proximity Read ↗

Noninvasively evaluating the grade and IDH mutation status of gliomas by using mono-exponential, bi-exponential diffusion-weighted imaging and three-dimensional pseudo-continuous arterial spin labeling.Semantic proximity Read ↗

Magnetic resonance imaging criteria for prediction of isocitrate dehydrogenase (IDH) mutation status in patients with grade II-III astrocytoma and oligodendroglioma.Semantic proximity Read ↗

Noninvasive Assessment of IDH Mutational Status in World Health Organization Grade II and III Astrocytomas Using DWI and DSC-PWI Combined with Conventional MR Imaging.Semantic proximity Read ↗

Regional and Volumetric Parameters for Diffusion-Weighted WHO Grade II and III Glioma Genotyping: A Method Comparison.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.